ClassID:

21498

A61K49/1812 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes; Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes

Recent Application in this class:
#1
20250371713
2025-12-04

Mapping glutathione deficiency and/or dysfunction of mitochondria

#2
20250288206
2025-09-18

SYSTEMS AND METHODS FOR MONITORING OF DELIVERY OF LABEL-FREE DRUGS

#3
20250281652
2025-09-11

TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION

#4
20250170280
2025-05-29

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF

#5
20250170279
2025-05-29

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF

#6
20250082787
2025-03-13

ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM

#7
20240148913
2024-05-09

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF

#8
20230398238
2023-12-14

TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION

#9
20230093684
2023-03-23

STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY

#10
20220265868
2022-08-25

Targeted contrast agents for MRI of alpha-synuclein deposition

#11
20220211880
2022-07-07

IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY

#12
20220152227
2022-05-19

STICKY PARTICLES FOR EFFICIENT IMAGING

#13
20220143225
2022-05-12

ULTRAFINE IRON OXIDE NANOPARTICLE-BASED MAGNETIC RESONANCE IMAGING T1 CONTRAST AGENT

#14
20220143224
2022-05-12

MRI CONTRAST AGENT FOR USE IN THE DIAGNOSIS OF EARLY CHANGES IN THE ENDOTHELIUM OF BLOOD VESSELS

#15
20220047726
2022-02-17

FORMATION AND USES OF EUROPIUM

#16
20220031869
2022-02-03

NANOCARRIER SYSTEMS FOR IMAGING AND DELIVERY OF ACTIVE AGENTS

#17
20220023445
2022-01-27

TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION

#18
20210369875
2021-12-02

ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM

#19
20210346524
2021-11-11

FUSOGENIC LIPOSOMES FOR SELECTIVE IMAGING OF TUMOR CELLS

#20
20210322313
2021-10-21

In-case stand for a musical instrument

#21
20210252170
2021-08-19

TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION

#22
20210236662
2021-08-05

Targeted contrast agents for MRI of amyloid deposition

#23
20210230134
2021-07-29

VITAMIN E DERIVATIVES AND THEIR USE AS MULTI-SCALE IMAGING AGENTS

#24
20210188774
2021-06-24

Targeting nanoparticles

#25
20210170055
2021-06-10

TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION

#26
20210128755
2021-05-06

TARGETING LIGANDS FOR TAU PATHOLOGY

#27
20210077637
2021-03-18

PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof

#28
20210077399
2021-03-18

MAGNETIC LIPOSOMES AND RELATED TREATMENT AND IMAGING METHODS

#29
20200397926
2020-12-24

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF

#30
20200179540
2020-06-11

MRI imaging of amyloid plaque using liposomes

#31
20200069820
2020-03-05

MRI IMAGING OF AMYLOID PLAQUE USING LIPOSOMES

#32
20200023082
2020-01-23

Formation and uses of europium

#33
20190381195
2019-12-19

Conjugated polymer-based nanoprobe and preparation method and application thereof

#34
20190338051
2019-11-07

PREPARATION METHOD FOR AND USE OF REDOX-RESPONSIVE CHITOSAN-LIPOSOME

#35
20190255196
2019-08-22

Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI

#36
20190125672
2019-05-02

Fabrication of Magnetic Vesicles for Biomedical Imaging and Delivery

#37
20190117572
2019-04-25

MICROFLUIDIC-FORMULATED LEUKOSOME COMPOSITIONS AND FABRICATION METHODS THEREFOR

#38
20190015526
2019-01-17

Hybrid membrane-coated nanoparticle composites and methods of making and using the same

#39
20180280546
2018-10-04

Stimuli-responsive magneto-plasmonic nanocarrier

#40
20180177728
2018-06-28

Nanoparticles

#41
20180169263
2018-06-21

Lipid-based drug carriers for rapid penetration through mucus linings

#42
20180154025
2018-06-07

Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signatures

#43
20180140672
2018-05-24

ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS

#44
20180085479
2018-03-29

Cathepsin-binding compounds bound to a carrier and their diagnostic use

#45
20180043039
2018-02-15

Lipid-based nanoparticles

#46
20170348440
2017-12-07

Liposome nanoparticles for tumor magnetic resonance imaging

#47
20170189564
2017-07-06

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

#48
20170173190
2017-06-22

Gadolinium expressed lipid nanoparticles for magnetic resonance imaging

#49
20170080111
2017-03-23

MRI imaging of amyloid plaque using liposomes

#50
20170035749
2017-02-09

Liposomes useful for drug delivery to the brain

#51
20160136306
2016-05-19

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

#52
20160101197
2016-04-14

MRI imaging of amyloid plaque using liposomes

#53
20160038616
2016-02-11

Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles

#54
20160022842
2016-01-28

FORMATION AND USES OF EUROPIUM

#55
20150313962
2015-11-05

Administration of growth factors for the treatment of CNS disorders

#56
20150283272
2015-10-08

Dual mode gadolinium nanoparticle contrast agents

#57
20150258220
2015-09-17

MAGNETIC RESONANCE IMAGING AND/OR SPECTROSCOPY CONTRAST AGENTS AND METHODS OF USE THEREOF

#58
20150247008
2015-09-03

Chelating amphiphilic polymers

#59
20150224201
2015-08-13

Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof

#60
20150182627
2015-07-02

LIPOSOME INCLUDING ACTIVE INGREDIENT AND IMAGING AGENT AND USE THEREOF

#61
20150086484
2015-03-26

Lipid-based drug carriers for rapid penetration through mucus linings

#62
20150064115
2015-03-05

NEUROPHILIC NANOPARTICLES

#63
20140227175
2014-08-14

Cathepsin-binding compounds bound to a carrier and their diagnostic use

#64
20140205657
2014-07-24

Method of producing a cationic liposomal preparation comprising a lipophilic compound

#65
20140205543
2014-07-24

METHOD FOR DIAGNOSING OR TREATING TUMORS USING SPHINGOMYELIN CONTAINING LIPOSOMES

#66
20140193330
2014-07-10

Compositions and methods for multimodal imaging

#67
20140178296
2014-06-26

TUMOR-TARGETED NANODELIVERY SYSTEMS TO IMPROVE EARLY MRI DETECTION OF CANCER

#68
20140161733
2014-06-12

BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE

#69
20140127135
2014-05-08

Lipidomimetic compounds and uses thereof

#70
20140056813
2014-02-27

Nanoparticles delivery systems, preparation and uses thereof

#71
20140017297
2014-01-16

Administration of growth factors for the treatment of CNS disorders

#72
20130343999
2013-12-26

Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications

#73
20130190605
2013-07-25

Methods and compositions for objectively characterizing medical images

#74
20130129636
2013-05-23

Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging

#75
20130108551
2013-05-02

Lipid bilayer carrier for drugs or imaging agents

#76
20120277573
2012-11-01

ULTRASOUND-ACTIVATED NANOPARTICLES AS IMAGING AGENTS AND DRUG DELIVERY VEHICLES

#77
20120258044
2012-10-11

Lipid-based nanoparticles

#78
20120141381
2012-06-07

Methods For Loading Contrast Agents Into A Liposome

#79
20120087975
2012-04-12

Method of producing a cationic liposomal preparation comprising a lipophilic compound

#80
20120087857
2012-04-12

GADOLINIUM EXPRESSED LIPID NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING

#81
20120045397
2012-02-23

Ultrasonically-triggered drug vehicle with magnetic resonance imaging function

#82
20120039810
2012-02-16

Aptamer-containing compositions and methods for targeting E-selectin

#83
20120009245
2012-01-12

Administration of growth factors for the treatment of CNS disorders

#84
20110286938
2011-11-24

Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles

#85
20110274617
2011-11-10

Antibody-Targeted Carrier For Contrast Agents

#86
20110243859
2011-10-06

ENCAPSULATING SYSTEM FOR CEST IMAGING WITH CHELATE Q GREATER THAN OR EQUAL TO 2

#87
20110223103
2011-09-15

Multimodal imaging of atherosclerotic plaque targeted to LOX-1

#88
20110195028
2011-08-11

Magnetic resonance imaging and/or spectroscopy contrast agents and methods of use thereof

#89
20110182821
2011-07-28

CLUSTERED MAGNETIC PARTICLES AS TRACERS FOR MAGNETIC PARTICLE IMAGING

#90
20110177009
2011-07-21

Drug carrier providing MRI contrast enhancement

#91
20110165087
2011-07-07

Targeted delivery of imaging probes for in vivo cellular imaging

#92
20110165074
2011-07-07

Chelating amphiphilic polymers

#93
20110135727
2011-06-09

Method of increasing the bioavailability of recombinant human insulin isophane in a patient

#94
20110110863
2011-05-12

COMPOSITIONS AND METHODS FOR PRODUCING EMULSIONS FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES AND OTHER APPLICATIONS

#95
20110104261
2011-05-05

REMOTE DETECTION OF SUBSTANCE DELIVERY TO CELLS

#96
20110045060
2011-02-24

KIT FOR DETECTING CANCER CELLS METASTASIZING INTO SENTINEL LYMPH NODE

#97
20110038926
2011-02-17

Method of producing a cationic liposomal preparation comprising a lipophilic compound

#98
20100254913
2010-10-07

NON-SPHERICAL CONTRAST AGENTS FOR CEST MRI BASED ON BULK MAGNETIC SUSCEPTIBILITY EFFECT

#99
20100247445
2010-09-30

POLYMERIC DRUG CARRIER FOR IMAGE-GUIDED DELIVERY

#100
20100226862
2010-09-09

MICROCAPSULE AND METHOD FOR MAGNETIC RESONANCE IMAGING TO LOCALIZE BLOOD

#101
20100178243
2010-07-15

Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system

#102
20100158817
2010-06-24

T1 MRI TRACKABLE DRUG DELIVERY PARTICLES, USES AND METHODS THEREOF

#103
20100135913
2010-06-03

Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

#104
20100111876
2010-05-06

Use of metal nanoparticles in the diagnosis of Alzheimer's disease

#105
20100098639
2010-04-22

Compositions and Methods for Convection Enhanced Delivery of High Molecular Weight Neurotherapeutics

#106
20100061938
2010-03-11

MRI TRACKABLE DRUG DELIVERY PARTICLES, USES AND METHODS THEREOF

#107
20090214419
2009-08-27

SELF-ASSEMBLED BIODEGRADABLE POLYMERSOMES

#108
20090191131
2009-07-30

USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS

#109
20090130022
2009-05-21

MRI CONTRAST MEDIUM CONTAINING LIPOSOMES

#110
20090130018
2009-05-21

SUPRAMOLECULAR AGGREGATES CONTAINING CHELATING AGENTS AND BIOACTIVE PEPTIDES AS EFFECTIVE AND SELECTIVE DELIVERY TOOLS FOR DRUGS AND CONTRAST AGENTS IN MRI OR NUCLEAR MEDICINE

#111
20080305037
2008-12-11

Linkers for anchoring targeting ligands

#112
20080299043
2008-12-04

Higher fatty acid triester compound having diethylenetriamine-type metal chelate structure

#113
20080206151
2008-08-28

Liposomes

#114
20080206131
2008-08-28

Compositions and method for multimodal imaging

#115
20080193384
2008-08-14

Responsive MRI contrast agents

#116
20070292354
2007-12-20

Contrast Agents Encapsulating Systems for Cest Imaging

#117
20070259031
2007-11-08

COMPOSITIONS AND METHODS FOR CONVECTION ENHANCED DELIVERY OF HIGH MOLECULAR WEIGHT NEUROTHERAPEUTICS

#118
20070254842
2007-11-01

Administration of growth factors for the treatment of CNS disorders

#119
20070243136
2007-10-18

Methods and compositions for imaging

#120
20070237721
2007-10-11

Targeted MR imaging agents

#121
20070231378
2007-10-04

Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof

#122
20070218056
2007-09-20

Methods for identification, diagnosis, and treatment of breast cancer

#123
20070202040
2007-08-30

Blood clot-targeted nanoparticles

#124
20070197904
2007-08-23

MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting

#125
20070196284
2007-08-23

Liposomal assembly for therapeutic and/or diagnostic use

#126
20070189974
2007-08-16

Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure

#127
20070189973
2007-08-16

Contrast medium comprising liposomes containing hydrophobic chelate compound

#128
20070140973
2007-06-21

CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING

#129
20070140965
2007-06-21

Methods to ameliorate and image angioplasty-induced vascular injury

#130
20070134154
2007-06-14

Tumor-targeted nanodelivery systems to improve early MRI detection of cancer

#131
20070110798
2007-05-17

Liposomes useful for drug delivery to the brain

#132
20070110674
2007-05-17

SONO-ACTIVE LIPOSOMES AND LIPID PARTICLES AND USE THEREOF AS CONTRAST AGENTS AND ACTIVE-AGENT DELIVERY SYSTEMS

#133
20060222697
2006-10-05

Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal

#134
20060128736
2006-06-15

Camptothecin-carboxylate formulations

#135
20060099148
2006-05-11

Methods and compositions for imaging

#136
20050232984
2005-10-20

Non-vesicular cationic lipid formulations

#137
20050202076
2005-09-15

Method of producing a cationic liposomal preparation comprising a lipophilic compound

#138
20050181038
2005-08-18

Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system

#139
20050136002
2005-06-23

Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters

#140
20050113675
2005-05-26

Ionic and non-ionic radiograhic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

#141
20050112065
2005-05-26

Remote detection of substance delivery to cells